Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response
| Autor: | Matthew R. Pawlus, Cheng-Jun Hu |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
Transcriptional Activation
Regulation of gene expression Tumor microenvironment Aryl hydrocarbon receptor nuclear translocator Carcinogenesis Promoter Cell Biology Biology medicine.disease_cause Molecular biology Article Enhanceosome Cell biology Gene Expression Regulation Hypoxia-inducible factors Basic Helix-Loop-Helix Transcription Factors Tumor Microenvironment medicine Animals Humans Hypoxia-Inducible Factor 1 Protein Interaction Maps Hypoxia Transcription factor |
| Zdroj: | Cellular Signalling. 25:1895-1903 |
| ISSN: | 0898-6568 |
| Popis: | Hypoxia is a prevalent attribute of the solid tumor microenvironment that promotes the expression of genes through posttranslational modifications and stabilization of alpha subunits (HIF1α and HIF2α) of hypoxia-inducible factors (HIFs). Despite significant similarities, HIF1 (HIF1α/ARNT) and HIF2 (HIF2α/ARNT) activate common as well as unique target genes and exhibit different functions in cancer biology. More surprisingly, accumulating data indicates that the HIF1- and/or HIF2-mediated hypoxia responses can be oncogenic as well as tumor suppressive. While the role of HIF in the hypoxia response is well established, recent data support the concept that HIF is necessary, but not sufficient for the hypoxic response. Other transcription factors that are activated by hypoxia are also required for the HIF-mediated hypoxia response. HIFs, other transcription factors, co-factors and RNA poll II recruited by HIF and other transcription factors form multifactorial enhanceosome complexes on the promoters of HIF target genes to activate hypoxia inducible genes. Importantly, HIF1 or HIF2 requires distinct partners in activating HIF1 or HIF2 target genes. Because HIF enhanceosome formation is required for the gene activation and distinct functions of HIF1 and HIF2 in tumor biology, disruption of the HIF1 or HIF2 specific enhanceosome complex may prove to be a beneficial strategy in tumor treatment in which tumor growth is specifically dependent upon HIF1 or HIF2 activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect